Biomarin Pharmaceutical (BMRN) Change in Inventory (2009 - 2026)
Biomarin Pharmaceutical's (BMRN) quarterly Change in Inventory came in at -$44.5 million in Q1 2026, down 282.82% YoY from $24.3 million in Q1 2025, and down 345.35% on a QoQ basis from $18.1 million in Q4 2025.
Biomarin Pharmaceutical (BMRN) Change in Inventory (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical (BMRN) has 18 years of Change in Inventory data on file, last reported at -$44.5 million in Q1 2026.
- Quarterly Change in Inventory fell 282.82% year-over-year to -$44.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.1 million (down 32.29% YoY) and the FY2025 annual result came in at $116.9 million, up 84.05% from the prior year.
- Change in Inventory eased to -$44.5 million in Q1 2026, from $18.1 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $59.1 million in Q4 2023 to a low of -$44.5 million in Q1 2026.
- A 5-year average of $21.3 million and a median of $26.0 million in 2022 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory soared 1557.98% — and 2026, when it sank 282.82%.
- Tracing BMRN's Change in Inventory over 5 years: stood at $40.8 million in 2022, then jumped by 44.72% to $59.1 million in 2023, then slumped by 42.02% to $34.3 million in 2024, then sank by 47.09% to $18.1 million in 2025, then plunged by 345.35% to -$44.5 million in 2026.
- The last three Change in Inventory figures came in at -$44.5 million (Q1 2026), $18.1 million (Q4 2025), and $26.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Biomarin Pharmaceutical | 13.04 Bn | 12.16 Bn | 786.91 Mn | 32.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.16 Mn |
| Jun 30, 2026 | 32.16 Mn |
| Mar 31, 2026 | -44.49 Mn |
| Mar 31, 2026 | -44.49 Mn |
| Dec 31, 2025 | 18.13 Mn |
| Dec 31, 2025 | 18.13 Mn |
| Sep 30, 2025 | 26.33 Mn |
| Sep 30, 2025 | 26.33 Mn |
| Jun 30, 2025 | 48.13 Mn |
| Jun 30, 2025 | 48.13 Mn |
| Mar 31, 2025 | 24.34 Mn |
| Mar 31, 2025 | 24.34 Mn |
| Dec 31, 2024 | 34.27 Mn |
| Dec 31, 2024 | 34.27 Mn |
| Sep 30, 2024 | -18.15 Mn |
| Sep 30, 2024 | -18.15 Mn |
| Jun 30, 2024 | 30.59 Mn |
| Jun 30, 2024 | 30.59 Mn |
| Mar 31, 2024 | 16.82 Mn |
| Mar 31, 2024 | 16.82 Mn |